Severine Lacourt

Severine Lacourt possesses extensive experience in the pharmaceutical and biotechnology sectors, with significant leadership roles at prominent companies. Currently serving as Vice President and Global Program Lead for LPA1 Lung Fibrosis at Bristol Myers Squibb, Severine has also held positions such as Worldwide Commercial Lead for Zeposia and for COVID-neutralizing monoclonal antibodies. Previous roles include BU Director for Ethicon Women Health & Urology at Johnson & Johnson, Global Marketing Director for Plavix at sanofi-aventis, and various marketing and consulting positions at GSK and The Boston Consulting Group. Severine completed a Master’s Degree in Entrepreneurship at HEC Paris and undertaken additional studies at INSEAD.